Bone Therapeutics to host Extraordinary General Meeting on 26 September 2022
REGULATED INFORMATION Preliminary documents for the Extraordinary General Meeting have been made available on company’s…
REGULATED INFORMATION Preliminary documents for the Extraordinary General Meeting have been made available on company’s…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company addressing tumor recurrence through cell-based immunotherapies, today…
Vancouver, British Columbia–(Newsfile Corp. – August 26, 2022) – Adamant Global Holding (CSE: ADMT) (OTC…
TOKYO, Aug 26, 2022 – (JCN Newswire) – Mitsubishi Corporation (MC) is pleased to announce…
HONG KONG, Aug 26, 2022 – (ACN Newswire) – On August 24, Wuling Motors (00305.HK),…
NEW CASTLE, Del.–(BUSINESS WIRE)–FS.COM, the high-speed communication solution provider for data centers, enterprises, and telecom…
— the 7th innovative drug in Junshi Biosciences’ pipeline to get IND approval from the…
Internet City, Dubai–(Newsfile Corp. – August 25, 2022) – LBank Exchange, a global digital asset…
Toronto, Ontario–(Newsfile Corp. – August 25, 2022) – DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB:…
Vancouver, British Columbia–(Newsfile Corp. – August 25, 2022) – Coloured Ties Capital Inc. (TSXV: TIE)…
One-day workshops in Mumbai and Delhi focus on technology and cybersecurity benefits of cloud video…
ATLANTA & NEW YORK–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of data,…
TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA:…
SOMERVILLE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
SAN DIEGO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Significant Milestones Achieved WINNIPEG, Manitoba, Aug. 25, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-…
Dr. Heron brings decades of experience in executive leadership and life sciences research and development…
SALT LAKE CITY, Aug. 25, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
WALTHAM, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…
NEWS RELEASE – REGULATED INFORMATION25 AUGUST 2022, 4:00PM EDT, 22:00 CET MDxHealth Reports Half Year…